Long-term use of adalimumab in the treatment of rheumatic diseases
Charalampos Papagoras, Paraskevi V Voulgari, Alexandros A DrososRheumatology Clinic, Department of Internal Medicine, Medical School, University of Ioannina, Ioannina, GreeceAbstract: Adalimumab, a fully humanized monoclonal antibody against tumor necrosis factor-alpha (TNF&alph...
Enregistré dans:
Auteurs principaux: | Charalampos Papagoras, Paraskevi V Voulgari, Alexandros A Drosos |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2009
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/43f28b6a51da4deab3b66a59004132da |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Long-term treatment of rheumatoid arthritis with adalimumab
par: Murdaca G, et autres
Publié: (2013) -
The role of adalimumab in rheumatic and autoimmune disorders: comparison with other biologic agents
par: Reimold AM
Publié: (2012) -
Efficacy and safety of adalimumab in ankylosing spondylitis
par: Mounach A, et autres
Publié: (2014) -
Certolizumab in the long-term treatment of rheumatoid arthritis
par: Scott DL, et autres
Publié: (2011) -
Prevalence of periprosthetic osteolysis after total hip replacement in patients with rheumatic diseases
par: Perez Alamino R, et autres
Publié: (2012)